| Year |
Citation |
Score |
| 2019 |
Zhang H, Deng M, Pei F, Wang S, Ho M. Next-Generation Antibody Therapeutics: Discovery, Development and Beyond: highlights of the third annual conference of the Chinese Antibody Society. Antibody Therapeutics. 2: 99-107. PMID 31942535 DOI: 10.1093/abt/tbz012 |
0.301 |
|
| 2017 |
Zhang YF, Ho M. Humanization of rabbit monoclonal antibodies via grafting combined Kabat/IMGT/Paratome complementarity-determining regions: rationale and examples. Mabs. 0. PMID 28165915 DOI: 10.1080/19420862.2017.1289302 |
0.301 |
|
| 2016 |
Zhang YF, Ho M. Humanization of high-affinity antibodies targeting glypican-3 in hepatocellular carcinoma. Scientific Reports. 6: 33878. PMID 27667400 DOI: 10.1038/srep33878 |
0.342 |
|
| 2015 |
Zhang YF, Phung Y, Gao W, Kawa S, Hassan R, Pastan I, Ho M. New high affinity monoclonal antibodies recognize non-overlapping epitopes on mesothelin for monitoring and treating mesothelioma. Scientific Reports. 5: 9928. PMID 25996440 DOI: 10.1038/srep09928 |
0.331 |
|
| 2013 |
Tang Z, Feng M, Gao W, Phung Y, Chen W, Chaudhary A, St Croix B, Qian M, Dimitrov DS, Ho M. A human single-domain antibody elicits potent antitumor activity by targeting an epitope in mesothelin close to the cancer cell surface. Molecular Cancer Therapeutics. 12: 416-26. PMID 23371858 DOI: 10.1158/1535-7163.MCT-12-0731 |
0.301 |
|
| 2012 |
Phung Y, Gao W, Man YG, Nagata S, Ho M. High-affinity monoclonal antibodies to cell surface tumor antigen glypican-3 generated through a combination of peptide immunization and flow cytometry screening. Mabs. 4: 592-9. PMID 22820551 DOI: 10.4161/mabs.20933 |
0.302 |
|
| 2009 |
Feng Y, Xiao X, Zhu Z, Streaker E, Ho M, Pastan I, Dimitrov DS. A novel human monoclonal antibody that binds with high affinity to mesothelin-expressing cells and kills them by antibody-dependent cell-mediated cytotoxicity. Molecular Cancer Therapeutics. 8: 1113-8. PMID 19417159 DOI: 10.1158/1535-7163.MCT-08-0945 |
0.32 |
|
| 2009 |
Ho M, Pastan I. In vitro antibody affinity maturation targeting germline hotspots. Methods in Molecular Biology (Clifton, N.J.). 525: 293-308, xiv. PMID 19252855 DOI: 10.1007/978-1-59745-554-1_15 |
0.341 |
|
| 2009 |
Ho M, Pastan I. Mammalian cell display for antibody engineering. Methods in Molecular Biology (Clifton, N.J.). 525: 337-52, xiv. PMID 19252852 DOI: 10.1007/978-1-59745-554-1_18 |
0.316 |
|
| 2006 |
Ho M, Nagata S, Pastan I. Isolation of anti-CD22 Fv with high affinity by Fv display on human cells. Proceedings of the National Academy of Sciences of the United States of America. 103: 9637-42. PMID 16763048 DOI: 10.1073/pnas.0603653103 |
0.329 |
|
| 2005 |
Ho M, Kreitman RJ, Onda M, Pastan I. In vitro antibody evolution targeting germline hot spots to increase activity of an anti-CD22 immunotoxin. The Journal of Biological Chemistry. 280: 607-17. PMID 15491997 DOI: 10.1074/jbc.M409783200 |
0.306 |
|
| 2003 |
Ho M, Segre M. Inhibition of cocaine binding to the human dopamine transporter by a single chain anti-idiotypic antibody: its cloning, expression, and functional properties. Biochimica Et Biophysica Acta. 1638: 257-66. PMID 12878327 DOI: 10.1016/S0925-4439(03)00091-7 |
0.638 |
|
| 2001 |
Ho M, Segre M. Cloning and sequence analysis of cDNAs encoding the heavy and light chain variable regions of an Ab2beta anti-idiotypic monoclonal antibody possessing an internal image of cocaine. Biochimica Et Biophysica Acta. 1521: 135-40. PMID 11690646 DOI: 10.1016/S0167-4781(01)00253-6 |
0.62 |
|
| 2001 |
Ho M, Segre M. Individual and combined effects of ethanol and cocaine on the human dopamine transporter in neuronal cell lines. Neuroscience Letters. 299: 229-33. PMID 11165777 DOI: 10.1016/S0304-3940(01)01526-9 |
0.599 |
|
| 2000 |
Ho M, Segre M. Dopamine uptake by mouse neuroblastoma N1E-115 cells stably expressing human dopamine transporter is differentially inhibited by anti-idiotypic ab2beta antibodies mimicking the configuration of cocaine. Brain Research. 872: 231-5. PMID 10924700 DOI: 10.1016/S0006-8993(00)02491-4 |
0.648 |
|
| Show low-probability matches. |